Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tadalafil and Tamsulosin for LUTS in BPH with Small Prostate Volume
NCT06809205Phase 4Completed
- Sponsor
- Fayoum University Hospital
- Start
- Apr 2023
- Primary completion
- May 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of tadalafil, tamsulosin in benign prostatic hyperplasia (BPH), sponsored by Fayoum University Hospital. Started Apr 2023; status: completed.
02
Drugs
tadalafiltamsulosin
03
Conditions
benign prostatic hyperplasia (BPH)
Beyond the preview
Go deeper on NCT06809205.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06809205.